This reminds me of when we moved up to 22.00 several months ago------------
We made big moves intraday and then closed at half those highs.,but they continued to move the stock up daily until we saw the 22.00 Only makes sense to me that we see 22.00 at least here,since the story is so much more positive now,while we`re waiting for full approval.
Given they have continued the trial and continue to increase the cure rate and the BT designation there is no reason for the FDA to stall on this - or the EU for that matter. We should get quick approval, well before six months, and be in market by year end to start the revenue generation process.
I`ll guess we start production in the first qtr of 15.,Any sooner would be unbelievable. I will say this,Piper came up with their last upgrade to 51 after meeting with INSM,so I think we see 50+ this year sometime.Just My opinion,I`d love to see more,but want to keep my expectations modest.